Llwytho...
Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
There is considerable interest and enthusiasm within the clinical gynecologic oncology community regarding the potential for poly (ADP-ribose) polymerase inhibitors to play a critically relevant role in the management of epithelial ovarian cancer and particularly (although not exclusively) in the se...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Womens Health (Lond) |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784554/ https://ncbi.nlm.nih.gov/pubmed/29313444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1745505717750694 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|